| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(01)00772-8 |
| P698 | PubMed publication ID | 11809536 |
| P50 | author | Takashi Ishikawa | Q98466535 |
| P2093 | author name string | Satoshi Hasegawa | |
| Kaoru Miyazaki | |||
| Yoji Nagashima | |||
| Hiroshi Shimada | |||
| Yasushi Ichikawa | |||
| Masako Kamiyama | |||
| Yohei Hamaguchi | |||
| Nailin Huo | |||
| P2860 | cites work | Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 |
| Molecular mechanisms that control endothelial cell contacts | Q33843553 | ||
| Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins | Q34479986 | ||
| T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation | Q35754623 | ||
| The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone | Q40853157 | ||
| Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model | Q41033779 | ||
| Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester | Q41057155 | ||
| Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors | Q41666730 | ||
| Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture. | Q42984887 | ||
| Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo | Q47848741 | ||
| The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells | Q62497033 | ||
| Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2) | Q67674017 | ||
| Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas | Q67863004 | ||
| Interstitial collagenase is required for angiogenesis in vitro | Q71617435 | ||
| Matrilysin is associated with progression of colorectal tumor | Q71768421 | ||
| Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration | Q73052540 | ||
| Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors | Q73564907 | ||
| Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9) | Q73853889 | ||
| Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation | Q74292354 | ||
| Complex role of matrix metalloproteinases in angiogenesis | Q77474882 | ||
| Matrix metalloproteinase expression in rat pancreatic islets | Q77576231 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 95-100 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells | |
| P478 | volume | 177 |
| Q37282674 | Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality |
| Q26823757 | Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin) |
| Q38350071 | Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy |
| Q37557752 | Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. |
| Q89861358 | MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients |
| Q33323694 | Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis |
| Q34002149 | Matrix metalloproteinase control of capillary morphogenesis |
| Q81864212 | Matrix metalloproteinases and angiogenesis |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q41970114 | Overexpression of endoglin (CD105) is associated with recurrence in radically resected gastric cancer. |
| Q35083186 | Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy |
| Q34408242 | Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer |
| Q38636963 | Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression. |
| Q47553825 | The Role of Wnt Signalling in Angiogenesis |
| Q40127968 | The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells |
| Q36604001 | The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma |
| Q100525119 | The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy |
Search more.